Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar;48(3):937-939.
doi: 10.1007/s00259-020-04966-w. Epub 2020 Aug 7.

Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma

Milena Pizzoferro  1 , Bartolomeo Cassano  2 , Claudio Altini  3 , Antonella Cacchione  4 , Maria Giuseppina Cefalo  4 , Vittorio Cannatà  2 , Maria Carmen Garganese  3
Affiliations
Case Reports

Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma

Milena Pizzoferro et al. Eur J Nucl Med Mol Imaging. 2021 Mar.
No abstract available

PubMed Disclaimer

References

    1. Chan M, Hsiao E. Incidental finding of cerebellar medulloblastoma on 68Ga-DOTATATE PET/CT in a patient with appendiceal carcinoid. Clin Nucl Med. 2016;41:886–7. https://doi.org/10.1097/RLU.0000000000001356 . - DOI - PubMed
    1. Khanna G, Bushnell D, O'Dorisio MS. Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors. Oncologist. 2008;13:382–9. https://doi.org/10.1634/theoncologist.2007-0175 . - DOI - PubMed
    1. Vaidyanathan G, Affleck DJ, Zhao XG, et al. [Lu]-DOTA-Tyr-octreotate: a potential targeted radiotherapeutic for the treatment of medulloblastoma. Curr Radiopharm. 2010;3:29–36. https://doi.org/10.2174/1874471011003010029 . - DOI - PubMed - PMC
    1. Cremonesi M, Ferrari ME, Bodei L, et al. Correlation of dose with toxicity and tumour response to 90 Y- and 177 Lu-PRRT provides the basis for optimization through individualized treatment planning. Eur J Nucl Med Mol Imaging. 2018;45:2426–41. https://doi.org/10.1007/s00259-018-4044-x . - DOI - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources